Castle biosciences inc.
Nov 9, 2023 · Castle Biosciences Inc’s price is currently up 9.67% so far this month. During the month of November, Castle Biosciences Inc’s stock price has reached a high of $19.36 and a low of $15.28. Over the last year, Castle Biosciences Inc has hit prices as high as $29.59 and as low as $9.26.
Castle Biosciences, Inc. (NASDAQ:CSTL) announced its quarterly earnings results on Sunday, November, 7th. The company reported ($0.47) EPS for the quarter, missing analysts' consensus estimates of ($0.34) by $0.13. The firm earned $23.48 million during the quarter, compared to the consensus estimate of $23.66 million.It’s estimated that there are over 30,000 castles in Ireland. Some are parts of ruins, some are homes, some are offices — and some castles in Ireland are available for people from all over the world to visit and stay in during their vacatio...DecisionDx - Melanoma - Castle Test Info. PHYSICIAN LOGIN | RESEARCHER LOGIN. CONTACT A. REPRESENTATIVE. ORDER A. TEST. TissueCypher®. Castle Biosciences is a molecular diagnostics company that provides tumor-specific information for improved treatment decisions and patient outcomes.Castle Biosciences, Inc. 820 S. Friendswood Drive, Suite 201 Friendswood, Texas 77546 (866) 788-9007 (Name, Address, Including Zip Code, and Telephone Number, Including Area Code, of Agent for Service) Copies to: Thomas A. Coll, Esq. Karen E. Deschaine, Esq. Cooley LLP 4401 Eastgate MallView the latest Castle Biosciences Inc. (CSTL) stock price, news, historical charts, analyst ratings and financial information from WSJ.
May 2018 - Present5 years 6 months. Baltimore, Maryland Area. 2019 Circle of Excellence Award Winner (178% to goal) 2021- 134.1% to goal. New business development of Castle Biosciences Cancer ...Age : 54. Public asset : 2,021,277 USD. Linked companies : Castle Biosciences, Inc. Summary. Kristen M. Oelschlager is Chief Operating Officer for Castle Biosciences, Inc. Ms. Oelschlager previously held the position of Clinical Research Coordinator at Maricopa County Special Health Care District (Arizona).FRIENDSWOOD, Texas--(BUSINESS WIRE)--Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced new data further ...
DecisionDx-Melanoma is a validated 31-gene expression profile (GEP) test that was developed to identify the risk of recurrence or metastasis including the likelihood of sentinel lymph node positivity for patients with stage I, II, or III melanoma and inform patient management decisions. The DecisionDx-Melanoma test accurately and independently ...Our new mailing address will be Castle Biosciences, Inc., 505 S. Friendswood Drive, Suite 401, Friendswood, Texas 77546. Stockholders may confirm our then-current mailing address by visiting our website at www.CastleBiosciences.com or by calling us at 1-866-788-9007.
Invisible Fence Inc. is a leading provider of innovative pet containment and lifestyle solutions. With over 40 years of experience, Invisible Fence Inc. has developed products that are designed to keep pets safe and secure in their own yard...Castle Biosciences, Inc. is a commercial-stage diagnostics company. The Company is focused on providing physicians and their patients with personalized, clinically actionable information to clinicians and their patients to inform treatment decisions and improve health outcomes.Castle Biosciences, Inc. is a commercial-stage dermatological cancer company, which engages in the provision of genomic information for physicians and patients. The firm offers DecisionDx-Melanoma ... 13 Apr 2022 ... Castle Bioscience Derek Maetzold expand. Derek Maetzold, president and CEO, Castle Biosciences Inc. Castle Biosciences Inc. Chris Mathews. By ...
Our DecisionDx-UM Seq is a 7-gene test that uses next-generation sequencing (NGS) to identify somatic mutations relevant to uveal melanoma. Researchers believe that identifying mutations in tumor genes may someday help guide treatment decisions. Because the amount of tumor biopsy tissue is limited, it is important to gain as much information as ...
Castle Biosciences, Inc., a company improving health through innovative tests that guide patient care, today announced its financial results for the third quarter and nine months ended September ...
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers.View a summary page of this 2023 CONTRACT to CASTLE BIOSCIENCES, INC. from the Department of Veterans Affairs.This Agreement and Plan of Merger (this “ Agreement”) is made and entered into as of October 18, 2021 (the “ Agreement Date”), by and among Castle Biosciences, Inc., a Delaware corporation (“ Acquirer”), Space Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of Acquirer (“ Merger Sub”), Cernostics, Inc., a Delaware …Castle Biosciences was founded by Derek Maetzold who believed that traditional methods to determine cancer patients’ prognosis could be improved by newly emerging techniques in molecular biology. We continue to focus on transforming disease management in areas of unmet clinical need through the development and marketing of innovative ...7 Jul 2023 ... ... Castle Biosciences Slumped This Week. featured-transcript-logo. Castle Biosciences, Inc. (CSTL) Q3 2019 Earnings Call Transcript. 524%. Premium ...The average Castle Biosciences, Inc. salary ranges from approximately $39,729 per year for Administrative Assistant to $106,781 per year for IT Engineer. Salary information comes from 20 data points collected directly from employees, users, and past and present job advertisements on Indeed in the past 36 months.If you're a new customer to Castle Biosciences, please call us when ordering a test. If a returning customer, you can use the requisition form.
CASTLE BIOSCIENCES, INC. CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) (in thousands) Six Months Ended. June 30, 2023 2022 OPERATING ACTIVITIES Net loss $ (47,981 ) $ ...View the latest Castle Biosciences Inc. (CSTL) stock price, news, historical charts, analyst ratings and financial information from WSJ. Castle Biosciences Reports Third Quarter 2023 Results. Published: Nov 02, 2023. Q3 2023 revenue increased 66% over Q3 2022 to $61 million. Q3 2023 total test reports increased 52% over Q3 2022. Raising full year 2023 revenue guidance to at least $200 million from at least $180 million. Conference call and webcast today at 4:30 p.m. ET.FRIENDSWOOD, Texas, June 03, 2023--Castle will share new data on DecisionDx®-Melanoma and DecisionDx®-UM during the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting.Belgium, a country known for its rich history, stunning architecture, and vibrant culture, offers a plethora of attractions for visitors to explore. From medieval castles to modern art galleries, Belgium has something for everyone.FRIENDSWOOD, Texas--(BUSINESS WIRE)--Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that the Centers for ...
Apr 5, 2022 · Castle Biosciences to acquire mental health testing co. AltheaDX in deal worth up to $140M. Friendswood-based diagnostics company Castle Biosciences Inc. (Nasdaq: CSTL) will acquire San Diego ... Order a test. Castle Biosciences is a molecular diagnostics company that provides tumor-specific information for improved treatment decisions and patient outcomes.
Castle Biosciences, Inc. (NASDAQ:CSTL) Q3 2022 Earnings Conference Call November 2, 2022 4:30 PM ET Company Participants Camilla Zuckero - Vice President, Investor Relations and Corporate AffairsMyPath Melanoma has over 35,000 clinically resulted cases and 9 publications including validation to outcomes. DiffDx-Melanoma offers a neural network, artificial intelligence-designed algorithm with a low rate of intermediate results. The test was validated in cutaneous melanocytic lesions to accurately differentiate between benign and ...An experienced team with deep expertise in discovering, developing, and commercializing diagnostic and prognostic tests. Castle Biosciences offers diagnostic tests that provide actionable, tumor-specific information for improved treatment decisions and patient outcomes.Castle Biosciences. Manufacturing · Texas, United States · 342 Employees. Castle Biosciences develops and commercializes diagnostic and prognostic tests for dermatologic cancers. Castle Biosciences is headquartered in Friendswood, Texas with operations in Phoenix, Arizona. Read More. View Company Info for FreeAug 2, 2023 · CASTLE BIOSCIENCES, INC. CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) (in thousands) Six Months Ended. June 30, 2023 2022 OPERATING ACTIVITIES Net loss $ (47,981 ) $ ... Castle Biosciences (Nasdaq: CSTL) is a commercial-stage dermatologic cancer company focused on providing physicians and their patients with personalized, clinically actionable genomic information ...Hayward Pool Products Inc. is a leading manufacturer and distributor of swimming pool equipment and supplies. With over 80 years of experience, the company has been at the forefront of innovation in the swimming pool industry.Operating Status Active. Last Funding Type Post-IPO Equity. Legal Name Castle Biosciences, Inc. Stock Symbol NASDAQ:CSTL. Company Type For Profit. Contact Email [email protected]. Phone Number 602-535-1997. Castle Biosciences is a biotech company that develops and validates diagnostic tests and technologies for the …Castle Biosciences, Inc. (NASDAQ: CSTL) Castle is a commercial-stage diagnostics company, focused on providing diagnostic and prognostic testing services for dermatological cancers and mental ...FRIENDSWOOD, Texas - Aug. 2, 2023--Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced its financial results for the second quarter and six months ended June 30, 2023.“Castle delivered an outstanding second quarter, with strength across our entire test portfolio,” …
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers.
At Castle Biosciences, we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance.
CASTLE BIOSCIENCES INC: Street Address 1 Street Address 2; 2014 SAN MIGUEL DR: City State/Province/Country ZIP/PostalCode Phone Number of Issuer; FRIENDSWOOD: TEXAS: 77546: 281-796-9032: 3. Related Persons. Last Name First Name Middle Name; Maetzold: Derek: Street Address 1 Street Address 2; c/o Castle Biosciences, Inc.Castle Learning Online’s products don’t come with ready-made answer keys, but they do provide instant feedback and answers once the student has gone through an assignment.Mar 20, 2023 · A look at the shareholders of Castle Biosciences, Inc. (NASDAQ:CSTL) can tell us which group is most powerful. The group holding the most number of shares in the company, around 85% to be precise ... FRIENDSWOOD, Texas--(BUSINESS WIRE)--Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced new data demonstrating ...FRIENDSWOOD, Texas--(BUSINESS WIRE)--Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced new data showing that ...PROGNOSTIC AIDS. Once melanoma diagnosis has been established, an innovative molecular assay that can be used to help in the prognosis is the Decision-Dx melanoma gene expression profiling test (Castle Biosciences). Prognosis requires traditional staging and includes looking at parameters like Breslow depth and mitotic …29 Jun 2023 ... 1Castle Biosciences, Inc, Friendswood, TX 2Surveillance Research Program, Division of Cancer Control & Population Sciences, National Cancer ...Castle Biosciences top competitors include: Biotheranostics Inc, DermTech, Agendia Inc, Athena Diagnostics Inc What companies has Castle Biosciences acquired?
Nov 17, 2023 · Castle Biosciences, Inc. (NASDAQ:CSTL) announced its quarterly earnings results on Sunday, November, 7th. The company reported ($0.47) EPS for the quarter, missing analysts' consensus estimates of ($0.34) by $0.13. The firm earned $23.48 million during the quarter, compared to the consensus estimate of $23.66 million. Order a test. Castle Biosciences is a molecular diagnostics company that provides tumor-specific information for improved treatment decisions and patient outcomes.Castle Biosciences, Inc. (CSTL) Q3 2023 Earnings Call Transcript SA Transcripts Fri, Nov. 03 Castle Biosciences GAAP EPS of -$0.26 beats by $0.50, revenue of $61.5M beats by $12.94MBoard Chairman. Daniel M. Bradbury has served as a member our board of directors since September 2012, and as chairman of our board of directors since September 2014. Mr. Bradbury is co-founder and Executive Chairman of Equillium, Inc., a publicly traded biotechnology company, where he also served as its CEO from June 2018 until January 2020 ...Instagram:https://instagram. mad money krameronline bank accounts with virtual cardsexxonmobil ceoralph lauren stock price 2022 Annual Report April 12, 2023 2022 Annual Report. 2022 Proxy Statement April 21, 2022 2022 Proxy Statement. 2021 Annual Report April 21, 2022 2021 Annual Report. 2021 Proxy Supplement May 13, 2021 2021 Proxy Supplement. 2021 Proxy Statement April 27, 2021 2021 Proxy Statement.Castle Biosciences Inc. balance sheet, income statement, cash flow, earnings & estimates, ratio and margins. View CSTL financial statements in full. resident physician personal loansbest trade software Castle Biosciences, Inc. is a commercial-stage dermatological cancer company, which engages in the provision of genomic information for physicians and patients. The firm offers DecisionDx-Melanoma ... cryptopunks for sale Castle Biosciences Named a Winner of the 2023 Top Workplaces USA Award for the Second Year! Castle Biosciences Inc. is growing, and we are looking to hire a Pre-Billing Prior Authorization ...April 04, 2022 04:05 PM Eastern Daylight Time. FRIENDSWOOD, Texas-- ( BUSINESS WIRE )--Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide ...